Facebook Instagram
Login
Patient Portal Login

The GLP Timeline:
From Discovery to Therapeutic Revolution

Way Better Starts here

What started as a gut hormone discovered in the 1980s has become one of the most groundbreaking medical advancements of our time. GLP-1 (Glucagon-Like Peptide-1) isn’t new science, it’s decades of research finally meeting real-world transformation. These naturally occurring peptides mimic the body’s own response to food, helping regulate blood sugar, appetite, and metabolism.

Today, GLP-1 receptor agonists including GLP-1 and GLP-1/GIP are changing how we approach diabetes, obesity, and even heart health. This timeline highlights the key breakthroughs, pivotal studies, and the incredible data that brought us here. We are taking you from early discovery all the way to the modern medications reshaping lives and longevity.

Early GLP-1 discoveries were inspired by lizard venom. Nature gave us the clue. Science turned it into one of the most well-studied and effective metabolic therapies in history.

1970
The Incretin Effect Emerges

In the 1970s, scientists first uncovered the “incretin effect,” – the discovery that the gut sends hormonal signals after you eat that boost insulin more than intravenous glucose. This was the foundational moment showing that digestion and hormone release are intimately linked to blood sugar control, setting the stage for decades of metabolic hormone research.

 

Pivotal Research: Early studies demonstrated that oral glucose prompted 50–70% more insulin secretion than the same amount given intravenously, indicating the presence of gut-derived incretins. 

 

Key Insight: This effect explains why eating carbohydrates feels satisfying. Your body naturally increases insulin through gut signaling, a process later amplified by GLP-1 therapies.

GLP-1 Peptide Discovered

Between 1982 and 1986, researchers decoded the proglucagon gene and discovered that it codes not only for glucagon but also for two novel peptides, including GLP-1. In 1986, Joel Habener and Svetlana Mojsov isolated the active form GLP-1 (7-37) from intestinal extracts, unlocking the hormone’s therapeutic promise.

 

Pivotal Research: Mojsov et al.’s 1983 work identified the insulin-stimulating fragment of the proglucagon gene precursor, GLP-1. 

 

Key Insight: Lizard venom meets medicine. The first GLP-1 analog was inspired by exendin 4, a peptide found in Gila monster saliva, showing how insights from nature helped shape modern metabolic therapy.

1987
First Human Trials

In 1987, GLP-1 transitioned from bench to bedside with the first human infusion trials. Patients with type 2 diabetes received GLP-1 (7-36) amide and showed enhanced insulin release only when glucose was elevated and importantly, without hypoglycemia. It proved GLP-1 was safe and effective in humans.

 

Pivotal Research: Kreymann & Bloom’s infusion study established GLP-1 (7-36) amide’s glucose-dependent insulinotropic effect in people with T2DM. 

 

Key Insight: Early doses of GLP-1 lowered post-meal blood sugar by 30–50%. A “eureka” moment proving gut hormones could assist diabetes therapy.

First Synthetic GLP-1 Agonist Invented

Jens Holst’s team at Novo Nordisk created a synthetic GLP-1 (7-37) analog, the first laboratory produced version stable enough for human use, overcoming the natural GLP-1 half life of just two minutes.

 

Pivotal Research: Deacon et al. engineered DPP-4 resistance, extending action to 30+ minutes. 

 

Key Insight: From 2 minutes to 12 hours, a 6000% increase in duration. This breakthrough made GLP-1 drugs possible.

Long-Acting GLP-1 Invented: Fatty Acid Tech

Novo Nordisk developed albumin-binding through fatty acid conjugation. This led to the creation of Liraglutide, the first once daily GLP-1 therapy that hitchhikes on blood proteins for a 13 hour half life.

 

Pivotal Research: Knudsen et al.'s patent showed 5x longer duration vs. native GLP-1.

 

Key Insight: Liraglutide achieved meaningful weight loss in the 5 to 10% range. Fatty acid conjugation simplified dosing into a once daily routine that fit easily into daily life.

First GLP-1 Drug Approved

2005 marked the first approval of a GLP-1 receptor agonist: exenatide (Byetta). Building on decades of research, Byetta translated the incretin concept into a medicine for type 2 diabetes, requiring twice-daily injections and introducing the world to GLP-1 therapy in clinical practice.

 

Pivotal Research: Phase 3 trials of exenatide showed A1C reductions of approximately 1.0 to 1.5% and weight loss of about 3 to 5 kg over approximately 30 weeks.

 

Key Insight: Byetta’s reptilian revolution, inspired by its lizard venom origins, led to use by over 1 million patients in its first decade. This moment helped launch a multibillion dollar market for GLP-1 therapies.

Oral GLP-1 Absorption Invented

Novo Nordisk's SNAC technology (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate) invented pill-form absorption, letting peptides survive stomach acid. This is the first oral GLP-1 breakthrough.

 

Pivotal Research: Bucci et al. proved 1% bioavailability vs. 0% for plain peptides.

 

Key Insight: After 20 years of research and development, stomach shield technology made oral GLP-1 possible. More than 5 million people now use Rybelsus as a needle free option.

Once-Daily Option: Liraglutide Arrives

In 2010, the GLP-1 class took a leap in convenience and potency with known brand, offering once-daily dosing and better metabolic outcomes. It built on the GLP-1 concept but with modifications that extended its half-life and expanded its reach into obesity.

 

Pivotal Research: The LEAD trials showed superior A1C reduction and cardiovascular safety for Liraglutide compared to older diabetes drugs.

 

Key Insight: Users lost an average of 5 to 10% of body weight on Liraglutide, roughly equivalent to shedding a bowling ball. This outcome demonstrated GLP-1’s dual benefit for glucose control and weight regulation.

Cardiovascular Breakthroughs

The period 2016–2017 was transformative: GLP-1 therapies proved their value beyond blood sugar. The LEADER trial and SUSTAIN-6 showed that GLP-1RAs cut major cardiovascular events, establishing a new standard in cardiometabolic care.

 

Pivotal Research: The LEADER trial (≈9,340 patients) revealed a 13% reduction in major cardiovascular events with Liraglutide.

 

Key Insight: These drugs reduced cardiovascular death risk by 20% to 26%, turning GLP-1RAs into “heart-health drugs” as well as metabolic ones.

GLP-1/GIP Invented: The Dual Powerhouse Emerges

Eli Lilly scientists engineered GLP-1/GIP (LY3298176), the first unimolecular dual GLP-1/GIP receptor agonist, blending GLP-1's insulin boost with GIP's glucose control for superior efficacy. This breakthrough built on GLP-1 foundations, promising even greater weight loss and metabolic wins.

 

Pivotal Research: Coskun et al.'s preclinical work detailed its biased agonism, showing enhanced potency over single-agonist therapies.

 

Key Insight: GLP-1/GIP delivers 15 to 22% weight loss, up to 50% more than GLP-1 alone, earning it the nickname twincretin for its dual hormone effect.

Oral GLP-1: Rybelsus Debuts

In 2019, the landscape shifted again: GLP-1 became available in a once-daily oral form (Rybelsus). For many patients, this meant GLP-1 therapy without injections, dramatically improving access and adherence.

 

Pivotal Research: The PIONEER trials demonstrated that oral GLP-1 provided comparable efficacy to injectable forms, with about a 1% reduction in A1C and 4 to 5 kg of weight loss.

 

Key Insight: The pill form uses a clever stomach shield absorption system first discovered in 2008. By 2025, more than 5 million prescriptions for oral GLP-1 had been written.

Weight Loss Expansion & Broader Benefits

Between 2021 and 2023, GLP-1 therapies were approved not just for diabetes, but also for obesity, causing a major shift. Higher-dose GLP-1 (Wegovy) showed robust weight loss and, in trials like SELECT, cardiovascular and other benefits in obese patients without diabetes.

 

Pivotal Research: In the STEP and SELECT trials, GLP-1 achieved 15–20% weight loss and a 20% reduction in cardiovascular events in high-risk obese individuals. 

 

Key Insight: Some users reported up to 40% fewer opioid cravings. Globally, GLP-1 therapies have helped over 10 million people lose weight, rivaling bariatric surgery outcomes without going under the knife.

Breakthrough of the Year Awarded

In 2023, GLP-1 based drugs were named Breakthrough of the Year by Science, a prestigious American journal. This recognition reflected their role in ushering a new era in obesity, helping to reshape attitudes to the condition and how it is treated. This year, clinical trials found that they also cut symptoms of heart failure and the risk of heart attacks and strokes, the most compelling evidence yet that the drugs have major benefits beyond weight loss itself. 

 

Pivotal Research: Obesity is no longer regarded as simply a failure of willpower but now a chronic illness with a biological cause. 

 

Key Insight: Richard DiMarchi, one of the pioneers of GLP-1 drugs, argues that the degree which they have helped to manage excess body weight compares with the historic breakthroughs in the management of excess blood pressure, excess lipids and excess glucose. As he says, “It's a truly phenomenal accomplishment and exceeds the expectations of most that have been associated with its history.”

First-Line for Heart Defense

By 2024–2025, GLP-1 therapies earned official recognition for cardiovascular prevention. The American College of Cardiology (ACC) endorsed GLP-1/dual-incretin drugs as first-line treatment for obese patients at risk of heart disease, cementing their role in cardiometabolic health.

 

Pivotal Research: The 2025 ACC guidelines include GLP-1/GIP agonists (e.g., GLP-1/GIP) for cardiovascular risk reduction in patients with obesity. 

 

Key Insight: Polling data suggests 12% of U.S. adults have tried GLP-1 therapies, with 8% of seniors using them for chronic conditions. This is a dramatic shift in public health.

Emerging Research on GLP-1’s Reach Beyond Metabolism

Turning down the volume on food noise. GLP-1 medicines act in the brain’s appetite and reward centers. Many people describe a noticeable quieting of constant food thoughts, fewer cravings, and more mental space for daily life. These effects work alongside slower stomach emptying and stronger fullness signals to support sustainable behavior change.

 

Pivotal research: A 2025 survey of 550 GLP-1 users revealed a meaningful shift in appetite signaling. Constant food thoughts declined from 62% before treatment to 16% on therapy.

 

Key Insight: In the same report, the participants who said food thoughts disrupted daily life dropped from 47% to 15%.

Alcohol Use: Cutting Cravings and Drinking

The brain processes food, alcohol, and nicotine through overlapping reward circuitry. This overlap has led researchers to explore GLP-1 therapies in addiction care, with early trials and real world data showing reduced alcohol cravings and lower intake.

 

Pivotal research: Randomized clinical trial in adults with alcohol use disorder. Weekly Semaglutide reduced alcohol cravings and alcohol self-administration versus placebo over 9 weeks. 

 

Key Insight: A Nature Communications analysis found Semaglutide users had about 50% to 56% lower risk of a new or recurrent alcohol use disorder diagnosis over one year versus matched peers on other weight loss meds. 

Nicotine Use: Early Signals in Smoking Reduction

GLP-1 activation appears to blunt nicotine reward in the brain. In people with diabetes who smoke, starting GLP-1 therapies has been linked to fewer tobacco-related visits and fewer cessation prescriptions, which hints at reduced use.

 

Pivotal research: Target trial emulation with U.S. real-world data showed lower tobacco use disorder events on Semaglutide compared with several diabetes comparators. Annals of Internal Medicine 2024 

 

Fun stat: In the JAMA Psychiatry alcohol study, participants on Semaglutide who also smoked reduced cigarette use more than those on placebo. 

Cancer Risk Signals in Obesity

Obesity, inflammation, and cancer risk are intertwined. Observational data in 2025 reported lower overall cancer incidence among adults with obesity who used GLP-1 medicines, with notable reductions in certain cancers.

 

Pivotal research: Retrospective cohort in JAMA Oncology found a 17% lower overall cancer risk among GLP-1 users versus non-users. Reductions were seen for endometrial, ovarian, and meningioma.

 

Key Insights: In that analysis, ovarian cancer risk was about 47% lower in GLP-1 users than in non-users.

Alzheimer’s Disease: Early Protective Signals

GLP-1 drugs show promise in protecting the brain. They may reduce insulin resistance in neurons and calm microglial inflammation, two processes tied to Alzheimer’s biology.

 

Pivotal research: U.S. target trial emulation found GLP-1 use associated with lower risk of a first Alzheimer’s diagnosis compared with several comparators. Alzheimer’s & Dementia 2024

 

Key Insight: A phase 2 study of Liraglutide in early Alzheimer’s reported about 18% less cognitive decline over 12 months and roughly 50% slower brain atrophy on MRI versus placebo. AAIC 2024 

Healthy Aging & Longevity: Healthspan First

GLP-1 medicines improve many pillars of healthy aging, including body composition, vascular health, and systemic inflammation. This is why geroscience researchers are studying them for healthspan, and possibly lifespan.

 

Pivotal research: Review on GLP-1 and healthy aging outlines potential to expand healthspan by reducing the multimorbidity that drives disability in later life. Aging Cell 2023

 

Key Insight: A 2024 narrative review called GLP-1 agents longevity therapeutics in disguise, since they lower rates of heart attack, stroke, kidney disease progression, and dementia in observational studies. Maturitas 2024

Microdosing Trials: Testing Tiny Doses for Older Adults

To separate cellular benefits from weight-loss side effects, researchers are piloting very low dose GLP-1 therapies in older adults without diabetes or obesity and tracking fitness, cognition, and inflammation.

 

Pivotal research: Clinical trial of microdosed GLP-1 in healthy older adults is underway with functional and inflammatory outcomes. ClinConnect NCT07092605

 

Key Insights If tiny doses improve inflammatory markers and energy without large weight loss, GLP-1 could become a periodic tune-up for aging, pending safety and efficacy.

Your Next Chapter Is Waiting

For decades, scientists have proven what’s possible. Now it’s your turn to experience it. The GLP-1 revolution isn’t just about weight loss or blood sugar. It’s about reclaiming control over how you look, feel, and age.

See All Treatment Options

Meet Your Way Better Mind Coach Sean

Image C

Hey, I’m Sean. And I want to start with something simple: you don’t need to be fixed.

The work we do here isn’t about adding more to your plate or pushing harder than you already are. It’s about getting underneath the patterns that have been quietly running the show, the ones you didn’t choose, that were shaped long before you had the tools to do anything about them.

I’ve spent over four decades in personal development, worked with thousands of people across the world, and trained through the Amen Clinics, one of the most respected brain health organizations in existence.

I’ve also written books, built programs, and made just about every mistake a person can make while trying to figure out how to actually change.

What I’ve learned is this: most people aren’t stuck because they lack discipline or desire. They’re stuck because they haven’t yet met the version of themselves that makes the right choices feel natural.

The answer, I found, lives deeper than motivation. It lives in identity, in the patterns wired into us long before we had the awareness to choose them, long before we even knew our own name.

That understanding became the foundation for NESS, Neuro Encoded Self Sculpting, a proprietary framework designed to help people understand how their mind actually works, recognize the patterns shaping their behavior, and begin building a version of themselves that reflects who they truly want to be.

That’s what Way Better Mind is built for. Through the NESS framework, and the tools, community, and experiences we’ve built around it, my goal is to help you understand how your mind works, recognize what’s been shaping your behavior, and start building something more aligned with who you want to be.

You’re not starting over. You’re seeing clearly, maybe for the first time.

And from here, everything changes.

Not because you’re becoming someone new.
But because you’re uncovering who you already are.

It's about to get Way Better! 

Sean

Continue Reading
Community & Pictures
Inside the Way Better Community, you'll unlock access to coaching typically reserved for the high-level performers. Their experience now becomes your advantage. Meet your fitness coach, Wes Okerson.

Wes is a renowned celebrity fitness trainer celebrated for his exceptional ability to transform the bodies and lives of high-profile clients, including tech mogul Jeff Bezos, Hollywood leading man Tom Cruise, and action star Gerard Butler. With over 20 years of training experience, Wes has built a reputation as a go-to expert for celebrities and high net worth individuals seeking to elevate their fitness and wellness.
His impressive journey in the fitness industry includes a notable appearance on NBC's hit series STRONG, where he not only showcased his expertise but also competed fiercely while guiding his trainee through an inspiring transformation over the course of ten thrilling episodes. Wes's dedication to his clients and innovative training methods have made him a sought after figure in the fitness realm.

Beyond his work with celebrities, Wes is an accomplished athlete himself. He currently competes as an age group pro in Hyrox, a demanding fitness competition that tests endurance and strength. His strong sports background as a collegiate pitcher and avid runner further enhances his understanding of athletic performance and conditioning.
Wes Okerson's passion for fitness, combined with his extensive experience and commitment to helping others, has led to countless success stories. His approach goes beyond mere physical transformation. He empowers individuals to embrace healthier lifestyles, ultimately changing lives one workout at a time.

This is what makes the Way Better Community different. You get elite coaching and meaningful support from people who care about your success. Together, they create the kind of momentum that changes everything.
Image A Image B Image C

Meet Your Pilates & Movement Coach Lindsay

Image C

Hi, I'm Lindsay! I am the founder of Pilates On Demand, a global online fitness community on YouTube, as well as a 450-Hour Certified Pilates Instructor and 500-Hour E-RYT Yoga Instructor.

My biggest joy is helping YOU move in ways that feel fresh, fun, and empowering. I draw heavily from my diverse background—which includes traveling to India to study for part of my yoga training—to create workouts that are intelligent and dynamic. Because who says fitness has to be boring?!

Our Vibe & Values

Here's the deal: you won't find anything about low-fat fads, weight-loss obsessions, or strict dieting here.

Instead, my space in Way Better Community fiercely prioritizes mental health and pure happiness right alongside building physical strength. We're all about celebrating movement, building resilience, and feeling absolutely AMAZING in your own skin.

I’m so excited to partner with Way Better Community because it brings together something I care deeply about, helping people feel stronger, more connected, and more at home in their bodies.

This isn’t just about workouts. It’s about creating real transformation in how you move, how you feel, and how you show up in your life. Getting to be part of a space that supports people on that kind of journey, alongside incredible coaches and a like-minded community, feels really special.

Beyond the Mat

When I'm not teaching, I'm an adventure enthusiast, mountain climber, travel bug, and total wine lover. Life's about balance, right?

Let's laugh, sweat, and conquer this journey together!

 

Continue Reading
Community & Pictures
Inside the Way Better Community, you'll unlock access to coaching typically reserved for the high-level performers. Their experience now becomes your advantage. Meet your fitness coach, Wes Okerson.

Wes is a renowned celebrity fitness trainer celebrated for his exceptional ability to transform the bodies and lives of high-profile clients, including tech mogul Jeff Bezos, Hollywood leading man Tom Cruise, and action star Gerard Butler. With over 20 years of training experience, Wes has built a reputation as a go-to expert for celebrities and high net worth individuals seeking to elevate their fitness and wellness.
His impressive journey in the fitness industry includes a notable appearance on NBC's hit series STRONG, where he not only showcased his expertise but also competed fiercely while guiding his trainee through an inspiring transformation over the course of ten thrilling episodes. Wes's dedication to his clients and innovative training methods have made him a sought after figure in the fitness realm.

Beyond his work with celebrities, Wes is an accomplished athlete himself. He currently competes as an age group pro in Hyrox, a demanding fitness competition that tests endurance and strength. His strong sports background as a collegiate pitcher and avid runner further enhances his understanding of athletic performance and conditioning.
Wes Okerson's passion for fitness, combined with his extensive experience and commitment to helping others, has led to countless success stories. His approach goes beyond mere physical transformation. He empowers individuals to embrace healthier lifestyles, ultimately changing lives one workout at a time.

This is what makes the Way Better Community different. You get elite coaching and meaningful support from people who care about your success. Together, they create the kind of momentum that changes everything.
Image A Image B Image C

Science Works
Better With Support

Wherever you’re starting from, the Way Better Community helps you turn goals into measurable progress.

 

Coaching you can trust

Guidance from expert coaches who help you turn “what I should do” into clear next steps you can actually follow.

Live Q&A and chat spaces

Ask questions, get unstuck, and get straightforward answers you can actually use instead of getting lost in internet rabbit holes.

Simple habits rooted in science

Build better routines around movement, meals, sleep, and stress without overhauling your whole life overnight.

Support that sticks

Connect with people reshaping their weight, energy, hormones, and longevity so you stay inspired and keep growing into your Way Better self, together.

Open to everyone at no fee

Join the Way Better Community

Already a member? Sign in

Meet Your Nutritionalist & Chef Coach Eric

Image A

Eric Triliegi is a performance nutritionist, chef, and combat-sports specialist with more than 15 years of experience helping elite athletes optimize performance through precision nutrition and advanced weight-management protocols.

Eric has worked closely inside professional training camps with many of the biggest names in combat sports and entertainment, including Conor McGregor, Logan Paul, Jake Paul, Ryan Garcia, Gervonta Davis, Caleb Plant, Anthony Pettis, Miesha Tate, and Carla Esparza, as well as internationally recognized artist Demi Lovato.

His approach centers around sports-specific nutrition, customized fueling strategies designed to match the exact metabolic, strength, endurance, and recovery demands of a given sport. Eric specializes in performance fueling and strategic fight-camp nutrition that helps athletes safely make weight while maintaining peak performance.

Eric gained national exposure as the nutritionist for Team Miesha Tate on Season 18 of the UFC reality series The Ultimate Fighter. 

He is also the author of Fight Food: Diet and Nutrition to Win at Life, where he shares many of the principles and systems he has developed working with high-performance athletes.

He created his cookbook to make performance nutrition more accessible and practical for individuals and families who want to feel confident in how they fuel their bodies without overcomplicating it. His approach focuses on delicious, effective recipes paired with guidance that makes it easier to stay consistent.

 

Today, Eric continues to work with elite competitors and high-performing individuals around the world, combining professional culinary expertise with cutting-edge sports nutrition to help clients perform at their absolute best.

He’s excited to partner with Way Better to give you the tools, support, and clarity to feel better, eat better, and build a way of living that actually fits your day to day life.

Continue Reading
Community & Pictures
Eric Triliegi is a performance nutritionist, chef, and combat-sports specialist with more than 15 years of experience helping elite athletes optimize performance through precision nutrition and advanced weight-management protocols.

Eric has worked closely inside professional training camps with many of the biggest names in combat sports and entertainment, including Conor McGregor, Logan Paul, Jake Paul, Ryan Garcia, Gervonta Davis, Caleb Plant, Anthony Pettis, Miesha Tate, and Carla Esparza, as well as internationally recognized artist Demi Lovato.
His approach centers around sports-specific nutrition—customized fueling strategies designed to match the exact metabolic, strength, endurance, and recovery demands of a given sport. Eric specializes in performance fueling, advanced weight-cut protocols, and strategic fight-camp nutrition that helps athletes safely make weight while maintaining peak performance.

Eric gained national exposure as the nutritionist for Team Miesha Tate on Season 18 of the UFC reality series The Ultimate Fighter. He is also the author of Fight Food: Diet and Nutrition to Win at Life, where he shares many of the principles and systems he has developed working with high-performance athletes.
Today, Eric continues to work with elite competitors and high-performing individuals around the world, combining professional culinary expertise with cutting-edge sports nutrition to help clients perform at their absolute best.
Image A Image B

Meet Your Fitness & Performance Coach Wes

Image C

Wes is a renowned celebrity fitness trainer celebrated for his exceptional ability to transform the bodies and lives of high-profile clients, including tech mogul Jeff Bezos, Hollywood leading man Tom Cruise, and action star Gerard Butler. With over 20 years of training experience, Wes has built a reputation as a go-to expert for celebrities and high net worth individuals seeking to elevate their fitness and wellness.

His impressive journey in the fitness industry includes a notable appearance on NBC's hit series STRONG,

where he not only showcased his expertise but also competed fiercely while guiding his trainee through an inspiring transformation over the course of ten thrilling episodes. Wes's dedication to his clients and innovative training methods have made him a sought-after figure in the fitness realm.

Beyond his work with celebrities, Wes is an accomplished athlete himself. He currently competes as an age group pro in Hyrox, a demanding fitness competition that tests endurance and strength. 

Wes Okerson's passion for fitness, combined with his extensive experience and commitment to helping others, has led to countless success stories. His approach goes beyond mere physical transformation. He empowers individuals to embrace healthier lifestyles, ultimately changing lives one workout at a time.

You deserve the same level of support that elite performers rely on. Expert coaches, practical guidance, and people who are invested in your success. Together, we can create momentum that changes everything.

Continue Reading
Community & Pictures
Inside the Way Better Community, you'll unlock access to coaching typically reserved for the high-level performers. Their experience now becomes your advantage. Meet your fitness coach, Wes Okerson.

Wes is a renowned celebrity fitness trainer celebrated for his exceptional ability to transform the bodies and lives of high-profile clients, including tech mogul Jeff Bezos, Hollywood leading man Tom Cruise, and action star Gerard Butler. With over 20 years of training experience, Wes has built a reputation as a go-to expert for celebrities and high net worth individuals seeking to elevate their fitness and wellness.
His impressive journey in the fitness industry includes a notable appearance on NBC's hit series STRONG, where he not only showcased his expertise but also competed fiercely while guiding his trainee through an inspiring transformation over the course of ten thrilling episodes. Wes's dedication to his clients and innovative training methods have made him a sought after figure in the fitness realm.

Beyond his work with celebrities, Wes is an accomplished athlete himself. He currently competes as an age group pro in Hyrox, a demanding fitness competition that tests endurance and strength. His strong sports background as a collegiate pitcher and avid runner further enhances his understanding of athletic performance and conditioning.
Wes Okerson's passion for fitness, combined with his extensive experience and commitment to helping others, has led to countless success stories. His approach goes beyond mere physical transformation. He empowers individuals to embrace healthier lifestyles, ultimately changing lives one workout at a time.

This is what makes the Way Better Community different. You get elite coaching and meaningful support from people who care about your success. Together, they create the kind of momentum that changes everything.
Image A Image B Image C